Investigating kinases to find new treatments for endometriosis
Kinases as Therapeutic Targets for Endometriosis
This study is looking at certain proteins that are higher in people with endometriosis to see if blocking them can lead to better treatment options, which could help improve care for those living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11088869 on NIH RePORTER |
What this research studies
This research focuses on identifying and validating specific kinases that are found to be elevated in patients with endometriosis. By using advanced techniques such as siRNA knockdown and small molecule inhibitors, the team aims to explore how inhibiting these kinases can lead to new therapeutic options. The study will also utilize innovative DNA-Encoded Chemistry Technology to discover and optimize new drugs that target these kinases. Patients with endometriosis may benefit from the development of more effective treatments that address the underlying mechanisms of their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with endometriosis, particularly those experiencing severe symptoms or complications.
Not a fit: Patients who do not have endometriosis or those whose condition is already effectively managed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for endometriosis, improving the quality of life for many patients.
How similar studies have performed: Previous research has shown promise in targeting kinases for various diseases, suggesting that this approach could be effective for endometriosis as well.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Matzuk, Martin M. — Baylor College of Medicine
- Study coordinator: Matzuk, Martin M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.